Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 02 Mar 2026 for VERTEX PHARMACEUTICALS INC / MA, €146k. Read the official filing
Filing timeline
BuySaleKristen Ambrose
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Kristen Ambrose: trading record in brief
This profile gathers the share dealings of Kristen Ambrose in Vertex Pharmaceuticals INC / MA, where the filings describe the role as senior executive. Over a trading history stretching from 1 February 2022 to 28 August 2026, the count stands at 25 filings.
No open-market purchase appears, only 4 sales worth €785k. Outside the open market, there are 21 share grants. So far in 2026, the count stands at no purchases and 1 sale.
The newest entry dates from 1 September 2026: a share grant, in Vertex Pharmaceuticals INC / MA. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kristen Ambrose
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations24 total
357 shares@ US$483.3612.4% of flowCommon StockSEC:0000875320-26-000125:0
546 shares@ US$485.1119.1% of flowCommon StockSEC:0000875320-26-000104:0
1,809 shares0Common StockSEC:0000875320-26-000080:0
1,393 shares@ US$487.7648.7% of flowCommon StockSEC:0000875320-26-000058:0
592 shares@ US$468.4119.8% of flowCommon StockSEC:0000875320-26-000036:0
2,950 shares0Common StockSEC:0001856587-26-000002:0
1,241 shares@ US$479.6119.0% of flowCommon StockSEC:0000875320-25-000122:0
828 shares@ US$483.2812.8% of flowCommon StockSEC:0000875320-25-000103:0
564 shares@ US$463.468.4% of flowCommon StockSEC:0000875320-25-000079:0
2,080 shares0Common StockSEC:0000875320-25-000057:0
591 shares@ US$467.989.0% of flowCommon StockSEC:0000875320-25-000033:0
2,566 shares0Common StockSEC:0000875320-25-000007:0
225 shares@ US$418.102.9% of flowCommon StockSEC:0000875320-24-000113:0
828 shares@ US$431.7911.1% of flowCommon StockSEC:0000875320-24-000097:0
591 shares@ US$422.747.8% of flowCommon StockSEC:0000875320-24-000041:0
1,374 shares@ US$420.2418.0% of flowCommon StockSEC:0000875320-24-000041:1
2,950 shares0Common StockSEC:0000875320-24-000016:0
289 shares@ US$329.823.0% of flowCommon StockSEC:0001209191-23-033312:0
176 shares@ US$313.741.7% of flowCommon StockSEC:0001209191-23-022689:0
502 shares@ US$289.124.6% of flowCommon StockSEC:0001209191-23-013695:0
2,566 shares0Common StockSEC:0001209191-23-006879:0
60 shares@ US$267.370.5% of flowCommon StockSEC:0000899243-22-015762:0
137 shares@ US$263.091.1% of flowCommon StockSEC:0000899243-22-013713:0
2,566 shares0Common StockSEC:0001209191-22-006761:0
24 of 24 declarations
